News
Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of ...
Recursion is eliminating approximately 20% of its workforce, in a restructuring that reflects challenges seen across the biopharma industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback